Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin Shoppe nearly doubles net income

This article was originally published in The Tan Sheet

Executive Summary

First-quarter net sales reach $191.6 million, up 11 percent, helping Vitamin Shoppe increase its net income 91.3 percent to $8.7 million. Diluted net income per share grew to 31 cents from 12 cents over first quarter 2009, Vitamin Shoppe said April 21. The North Bergen, N.J.-based company reported comparable same-store sales grew 6.2 percent, or $9.3 million, in the three months ended March 27, marking the 18 consecutive quarter of growth by that measure. Vitamin Shoppe, with 453 current locations, opened 16 stores in the January-March period and projects 42 total openings in 2010. Executive VP and Chief Financial Officer Michael Archbold said during a same-day earnings call that the firm projects mid-single-digit growth for comp-store sales for the year, with an expected degree of cannibalization as new locations open

You may also be interested in...



Stock Watch: The Rise Of Vaccine Cannibalism

Influenza and pneumococcal vaccine sales were initially strong at the start of the pandemic. Recent weak revenues for travel, childhood and premium vaccines could raise population immunity concerns, however.

Inter Parfums Hungry For New Brand Licenses With Q1 Sales Up 37%

Inter Parfums is targeting deals with "evergreen-type" brands doing around $50m in annual sales that could benefit from its expertise and extensive distribution network. The firm’s first-quarter sales totaled $198.5m, an increase of 11% compared with 2019 levels and 37% versus the prior-year period.

Podcast: The Week In European Consumer Health Industry News, 17 May 2021

HBW Insight editors Tom Gallen and David Ridley discuss the big issues in the European consumer healthcare market. This week, they look at the Q1 financials of four major European OTC players - GSK, Sanofi, Bayer and Reckitt - to assess the ongoing impact of COVID-19.

Topics

UsernamePublicRestriction

Register

PS104050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel